{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:41:23Z","timestamp":1785469283838,"version":"3.56.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20384"],"award-info":[{"award-number":["U22A20384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173726"],"award-info":[{"award-number":["82173726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973259"],"award-info":[{"award-number":["81973259"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574341"],"award-info":[{"award-number":["82574341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L242056"],"award-info":[{"award-number":["L242056"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007928","name":"Ningbo Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["2022Z142"],"award-info":[{"award-number":["2022Z142"]}],"id":[{"id":"10.13039\/501100007928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["BMU2022XY024"],"award-info":[{"award-number":["BMU2022XY024"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025T180979"],"award-info":[{"award-number":["2025T180979"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.apsb.2025.12.029","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:23:47Z","timestamp":1766507027000},"page":"4654-4675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced tumor immunotherapy by nanovesicles derived from engineered DC-like M1 macrophage"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6267-9456","authenticated-orcid":false,"given":"Linxia","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1702-8096","authenticated-orcid":false,"given":"Xiaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9648-7018","authenticated-orcid":false,"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.12.029_bib1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib3","article-title":"Enhanced tumor immunotherapy by triple amplification effects of nanomedicine on the STING signaling pathway in dendritic cells","volume":"14","author":"Wang","year":"2025","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2025.12.029_bib4","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1016\/j.apsb.2024.06.006","article-title":"Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes","volume":"14","author":"Wan","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.029_bib5","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","article-title":"Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy","volume":"27","author":"Pitt","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2025.12.029_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.12.029_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb6981","article-title":"Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment","volume":"13","author":"Wang","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2025.12.029_bib8","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2025.12.029_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau4292","article-title":"Direct reprogramming of fibroblasts into antigen-presenting dendritic cells","volume":"3","author":"Rosa","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4817","article-title":"Restoring tumor immunogenicity with dendritic cell reprogramming","volume":"8","author":"Zimmermannova","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn9083","article-title":"In vivo dendritic cell reprogramming for cancer immunotherapy","volume":"386","author":"Ascic","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.12.029_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg5539","article-title":"Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells","volume":"7","author":"Rosa","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.12.029_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001341","article-title":"Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer","volume":"9","author":"Li","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2025.12.029_bib15","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1021\/acsnano.8b02446","article-title":"M1 Macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors","volume":"12","author":"Choo","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.12.029_bib16","article-title":"Biointerface-engineered hybrid nanovesicles for targeted reprogramming of tumor microenvironment","volume":"36","author":"Zhen","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.12.029_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301163","article-title":"Programming cell-derived vesicles with enhanced immunomodulatory properties","volume":"12","author":"Neupane","year":"2023","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2025.12.029_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.12659\/MSM.896951","article-title":"Culture and identification of mouse bone marrow-derived dendritic cells and their capability to induce T lymphocyte proliferation","volume":"22","author":"Wang","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.apsb.2025.12.029_bib19","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41423-023-01081-2","article-title":"FBXO38 regulates macrophage polarization to control the development of cancer and colitis","volume":"20","author":"Zheng","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib20","article-title":"Isolation of murine peritoneal macrophages to carry out gene expression analysis upon toll-like receptors stimulation","volume":"29","author":"Santos","year":"2015","journal-title":"J Vis Exp"},{"key":"10.1016\/j.apsb.2025.12.029_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.22203\/eCM.v050a09","article-title":"Hypoxia-derived mesenchymal stem-cell exosomes delivering naringin enhance osteoblast migration and fracture healing by upregulating integrin \u03b21 via the BDNF\u2013TrkB\/ERK1\/2 signaling pathway","volume":"50","author":"Yao","year":"2025","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.apsb.2025.12.029_bib22","first-page":"364","article-title":"Synthesis of folate modified chitosan-based nanomicelles and its in vitro anti-tumor activity","volume":"49","author":"Liu","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.apsb.2025.12.029_bib23","first-page":"204","article-title":"Eliminating the original cargos of glioblastoma cell-derived small extracellular vesicles for efficient drug delivery to glioblastoma with improved biosafety","volume":"16","author":"Guo","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2025.12.029_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12951-024-02636-9","article-title":"Cargo-eliminated osteosarcoma-derived small extracellular vesicles mediating competitive cellular uptake for inhibiting pulmonary metastasis of osteosarcoma","volume":"22","author":"Lin","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.12.029_bib25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib26","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/s41467-018-04985-0","article-title":"Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway","volume":"9","author":"Tang-Huau","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.12.029_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-024-44787-1","article-title":"Tumour-retained activated CCR7(+) dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity","volume":"15","author":"Lee","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.12.029_bib28","article-title":"Aggregation-induced-emission photosensitizer-loaded nano-superartificial dendritic cells with directly presenting tumor antigens and reversed immunosuppression for photodynamically boostedimmunotherapy","volume":"35","author":"Sun","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.12.029_bib29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.apsb.2019.01.015","article-title":"Kinsenoside attenuates osteoarthritis by repolarizing macrophages through inactivating NF-kappaB\/MAPK signaling and protecting chondrocytes","volume":"9","author":"Zhou","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.029_bib30","first-page":"105","article-title":"Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity","volume":"4","author":"He","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib31","article-title":"Nanomedicines reprogram synovial macrophages by scavenging nitric oxide and silencing CA9 in progressive osteoarthritis","volume":"10","author":"Yan","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.12.029_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.12.029_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2022.100004","article-title":"Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles","volume":"1","author":"Wen","year":"2022","journal-title":"Extracell Vesicle"},{"key":"10.1016\/j.apsb.2025.12.029_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12951-024-02721-z","article-title":"Nebulized milk exosomes loaded with siTGF-beta1 ameliorate pulmonary fibrosis by inhibiting EMT pathway and enhancing collagen permeability","volume":"22","author":"Qiu","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.12.029_bib35","first-page":"1163","article-title":"Natural endogenous material-based vehicles for delivery of macromolecular drugs","volume":"22","author":"Lu","year":"2024","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.apsb.2025.12.029_bib36","article-title":"Cell membrane-derived nanovesicles as extracellular vesicle-mimetics in wound healing","volume":"31","author":"Li","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.apsb.2025.12.029_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.12.029_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12441","article-title":"Anti-cancer therapy with TNFalpha and IFNgamma: a comprehensive review","volume":"51","author":"Shen","year":"2018","journal-title":"Cell Prolif"},{"key":"10.1016\/j.apsb.2025.12.029_bib39","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.it.2023.09.003","article-title":"IL-2-driven CD8(+) T cell phenotypes: implications for immunotherapy","volume":"44","author":"Niederlova","year":"2023","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.12.029_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.12.029_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.12.029_bib43","article-title":"Tumor microenvironment-responsive nanoparticles amplifying STING signaling pathway for cancer immunotherapy","volume":"36","author":"Liu","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.12.029_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.apsb.2025.12.029_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101041","article-title":"The promising role of tumor-associated macrophages in the treatment of cancer","volume":"73","author":"Wang","year":"2024","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.apsb.2025.12.029_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112466","article-title":"Exosome microRNA-125a-5p derived from epithelium promotes M1 macrophage polarization by targeting IL1RN in chronic obstructive pulmonary disease","volume":"137","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apsb.2025.12.029_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41464","article-title":"MiR- 146b-5p inhibits Candida albicans-induced inflammatory response through targeting HMGB1 in mouse primary peritoneal macrophages","volume":"11","author":"Cheng","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.apsb.2025.12.029_bib48","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1159\/000470822","article-title":"MicroRNA-9 inhibits NLRP3 inflammasome activation in human atherosclerosis inflammation cell models through the JAK1\/STAT signaling pathway","volume":"41","author":"Wang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.apsb.2025.12.029_bib49","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4240\/wjgs.v15.i4.600","article-title":"Acinous cell AR42J-derived exosome miR125b-5p promotes acute pancreatitis exacerbation by inhibiting M2 macrophage polarization via PI3K\/AKT signaling pathway","volume":"15","author":"Zheng","year":"2023","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.apsb.2025.12.029_bib50","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41467-019-11911-5","article-title":"Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.12.029_bib51","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ni.2304","article-title":"Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization","volume":"13","author":"Xu","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2025.12.029_bib52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jmcb\/mjv042","article-title":"The transcription factor PU.1 promotes alternative macrophage polarization and asthmatic airway inflammation","volume":"7","author":"Qian","year":"2015","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.apsb.2025.12.029_bib53","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.apsb.2024.03.004","article-title":"M1-polarized macrophage-derived cellular nanovesicle-coated lipid nanoparticles for enhanced cancer treatment through hybridization of gene therapy and cancer immunotherapy","volume":"14","author":"Shin","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.029_bib54","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.trecan.2023.07.015","article-title":"Modulating Treg stability to improve cancer immunotherapy","volume":"9","author":"Kang","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.apsb.2025.12.029_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2162-3619-1-10","article-title":"Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis","volume":"1","author":"Rafiyath","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.apsb.2025.12.029_bib56","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-15-0064","article-title":"The interplay of immunotherapy and chemotherapy: harnessing potential synergies","volume":"3","author":"Emens","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.apsb.2025.12.029_bib57","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.apsb.2023.12.001","article-title":"A pH\/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.029_bib58","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jconrel.2022.06.039","article-title":"Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression","volume":"348","author":"Kim","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.029_bib59","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acs.accounts.3c00771","article-title":"Nanomedicines for an enhanced immunogenic cell death-based in situ cancer vaccination response","volume":"57","author":"Zhao","year":"2024","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2025.12.029_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2016.02.035","article-title":"Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K(b) and H-2D(b)-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma","volume":"228","author":"Zhuang","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.029_bib61","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.apsb.2022.08.020","article-title":"Cellular nanovesicles for therapeutic immunomodulation: a perspective on engineering strategies and new advances","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm Sin B"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:12:14Z","timestamp":1783714334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525008378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2211383525008378"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.029","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced tumor immunotherapy by nanovesicles derived from engineered DC-like M1 macrophage","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}